APA (7th ed.) Citation

Osipova, O. A., Gosteva, E. V., Golivets, T. P., Belousova, O. N., Zemlyansky, O. A., Pokrovsky, M. V., . . . Merezhko, A. A. (2021). Changes of myocardial fibrosis markers with the use of beta-blockers and mineralocorticoid receptor antagonists in patients with heart failure with mid-range ejection fraction of ischemic origin. «SILICEA-POLIGRAF» LLC.

Chicago Style (17th ed.) Citation

Osipova, O. A., E. V. Gosteva, T. P. Golivets, O. N. Belousova, O. A. Zemlyansky, M. V. Pokrovsky, A. I. Golovin, N. V. Grigorenko, and A. A. Merezhko. Changes of Myocardial Fibrosis Markers with the Use of Beta-blockers and Mineralocorticoid Receptor Antagonists in Patients with Heart Failure with Mid-range Ejection Fraction of Ischemic Origin. «SILICEA-POLIGRAF» LLC, 2021.

MLA (9th ed.) Citation

Osipova, O. A., et al. Changes of Myocardial Fibrosis Markers with the Use of Beta-blockers and Mineralocorticoid Receptor Antagonists in Patients with Heart Failure with Mid-range Ejection Fraction of Ischemic Origin. «SILICEA-POLIGRAF» LLC, 2021.